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Many nutritional factors influence bone, from the basics of calcium and vitamin D, to factors 
which influence bone through acid/base balance, including protein, sodium, and more. Fibroblast growth 
factor 23 (FGF23) is a recently identified factor, secreted from osteocytes, which is involved in classic 
(albeit complex) feedback loops controlling phosphorus homeostasis through both vitamin D and 
parathyroid hormone (PTH) (1, 2). As osteocytes are gravity sensing cells, it is important to determine if 
there are changes in FGF23 during spaceflight. In extreme cases, such as chronic kidney disease, FGF23 
levels are highly elevated. FGF23 imbalances, secondary to dietary influences, may contribute to skeletal 
demineralization and kidney stone risk during spaceflight.  
Presented with an imbalanced dietary phosphorus to calcium ratio, increased secretion of FGF23 
will inhibit renal phosphorus reabsorption, resulting in increased excretion and reduced circulating 
phosphorus. Increased intake and excretion of phosphorus is associated with increased kidney stone risk 
in both the terrestrial and microgravity environments. Highly processed foods and carbonated beverages 
are associated with higher phosphorus content.  Ideally, the dietary calcium to phosphorus ratio should be 
at minimum 1:1. Nutritional requirements for spaceflight suggest that this ratio not be less than 0.67 (3), 
while the International Space Station (ISS) menu provides 1020 mg Ca and 1856 mg P, for a ratio of 0.55 
(3). Subjects in NASA’s bed rest studies, by design, have consumed intake ratios much closer to 1.0 (4). 
FGF23 also has an inhibitory influence on PTH secretion and 1α-hydroxylase, both of which are 
required for activating vitamin D with the conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin 
D.  Decreased 1,25-dihydroxyvitamin D will result in decreased intestinal phosphorus absorption, and 
increased urinary phosphorus excretion (via decreased renal reabsorption). Should a decrease in 1,25-
dihydroxyvitamin D be necessary to reduce intestinal phosphorus absorption, calcium absorption will also 
proportionally be reduced, potentially leading to skeletal demineralization. Demineralization of bone can 
increase kidney stone risk, a medical issue that could prove detrimental to mission success.    
Given the interrelationships described above, we sought to determine circulating FGF23 
concentrations in spaceflight and ground analog studies to better understand the potential effects of 
dietary phosphorus on bone and calcium metabolism.  We analyzed serum from ISS astronauts 
participating in studies of bone biochemistry, including the Nutrition SMO and Pro K experiments, and 
we also evaluated FGF23 during extended-duration bed rest.  Serum intact FGF23 levels were determined 
using an ELISA kit from Kainos laboratories in Japan. While initial evaluation of the data showed no 
changes over time during flight or bed rest, evaluation continues of FGF23 data in light of dietary factors, 
PTH, vitamin D status, and other biochemical and endocrine factors.   
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